therapies

Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and…

1 year ago

Team finds a stem-cell derived mechanism that could lead to regenerative therapies for heart damage

A UCLA-led team has identified an essential internal control mechanism that can promote the maturation of human stem cell-derived heart…

2 years ago